US judge says layoffs at Department of Health and Human Services were likely unlawful and must be halted
US District Judge Melissa DuBose granted the preliminary injunction sought by a coalition of attorneys general from 19 states and the District of Columbia in a lawsuit filed in early May.
DuBose said the states had shown 'irreparable harm,' from the cuts and were likely to prevail in their claims that 'HHS's action was both arbitrary and capricious as well as contrary to law.'
'The executive branch does not have the authority to order, organize, or implement wholesale changes to the structure and function of the agencies created by Congress,' DuBose wrote in a 58-page order handed down in US District Court in Providence, Rhode Island, on Tuesday.
Her order blocks the Trump administration from finalizing layoffs announced in March or issuing any further firings. HHS is directed to file a status report by July 11.
The ruling applies to terminated employees in four divisions of HHS: the US Centers for Disease Control and Prevention; the Center for Tobacco Products within the Food and Drug Administration; the Office of Head Start within the Administration for Children and Families and employees of regional offices who work on Head Start matters; and the Office of the Assistant Secretary for Planning and Evaluation.
Health Secretary Robert F. Kennedy Jr. eliminated more than 10,000 employees in late March and consolidated 28 agencies to 15. Since then, agencies including the CDC have repeatedly rescinded layoffs affecting hundreds of employees, including in branches that monitor HIV, hepatitis and other diseases.
The attorneys general argued that the massive restructuring was arbitrary and outside of the scope of the agency's authority. The lawsuit also says that the action decimated essential programs and pushed burdensome costs onto states.
'The intended effect … was the wholesale elimination of many HHS programs that are critical to public health and safety,' the lawsuit argued.
The cuts are part of a federal 'Make America Healthy Again' directive to streamline costly agencies and reduce redundancies. Kennedy told senators at a May 14 hearing that there is 'so much chaos and disorganization' at HHS.
But the restructuring had eliminated key teams that regulate food safety and drugs, as well as support a wide range of programs for tobacco, HIV prevention and maternal and infant health. Kennedy has since said that because of mistakes, 20% of people fired might be reinstated.
The states who joined the lawsuit have Democratic governors, and many of the same states — plus a few others — also sued the Trump administration over $11 billion in cuts to public health funding. A preliminary injunction was granted in that case in mid-May.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
28 minutes ago
- Axios
Medicaid effort to target undocumented immigrants may create enrollment hurdles
Federal health officials announced a new push on Tuesday to ensure that Medicaid and Children's Health Insurance Program (CHIP) enrollees are U.S. citizens or have a satisfactory immigration status. Why it matters: The effort could create new administrative hoops for enrollees to jump through. Driving the news: The Centers for Medicare and Medicaid Services will begin providing states with "monthly enrollment reports identifying individuals whose citizenship or immigration status could not be confirmed through federal databases," the Department of Health and Human Services said in a statement. The reports will draw on data from sources including the Department of Homeland Security's Systematic Alien Verification for Entitlements (SAVE) program. HHS emphasized that states are responsible for reviewing cases, verifying the immigration status of individuals on the CMS' reports, and "taking appropriate actions." All states will receive these reports within the next month, per the HHS. Reality check: Traditional Medicaid coverage is not available to undocumented immigrants. "Undocumented immigrants are not eligible to enroll in federally funded coverage including Medicaid, CHIP, or Medicare or to purchase coverage through the ACA Marketplaces," per the non-partisan Kaiser Family Foundation. HHS did not respond to Axios' request for comment. What they're saying:"Every dollar misspent is a dollar taken away from an eligible, vulnerable individual in need of Medicaid and CHIP," said CMS Administrator Dr. Mehmet Oz. Between the lines: The change looks to put the burden of proof on the individuals whose immigration statuses the CMS cannot verify through the databases. By the numbers: Despite the assertions of Oz — and other parts of President Trump's administration — there is not evidence that undocumented immigrants are broadly receiving Medicaid benefits they're not eligible for. Medicaid reimburses hospitals for emergency care provided to individuals who meet other eligibility requirements but lack eligible immigration status. Emergency spending rose less than 1% of total Medicaid spending between 2017 and 2023, according to KFF. Immigrants in the country legally may also qualify for Medicaid or CHIP, but face eligibility restrictions. There is a five-year waiting period for these modified forms of Medicaid and CHIP, which states can eliminate for children and pregnant people. An early version of Republicans recently passed tax-and-spending bill would have cut federal payments to states that covered undocumented immigrants with their own funds. The provision was dropped after it was found to violate Senate rules. The White House claimed that the provision would "protect Medicaid for Americans by removing at least 1.4 million illegal immigrants from the program." The other side: The 1.4 million figure "is unequivocally false," according to Georgetown University's Center for Families and Children.
Medscape
28 minutes ago
- Medscape
Smartwatches Won't Fix the Burnout Crisis in Medicine
This transcript has been edited for clarity. Welcome to Impact Factor , your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson from the Yale School of Medicine. Burnout is a huge problem across multiple professions in the United States. Grades K-12 teachers have about a 50% burnout rate. So do people in quality assurance. But I was unable to find a profession with a higher rate of burnout, or a higher potential for harm from burnout, than — you guessed it — physicians. A 2022 survey found that 63% of physicians had burnout, rates that have been among the highest of all US workers since 2011. And this is a huge problem. When docs are burned out, they are more likely to commit medical errors, be named in malpractice suits, and even exhibit racial biases. Administrators of health systems have taken notice. But their solutions have often been criticized as tone-deaf. 'Mandatory burnout workshops' are not helping anyone's burnout, I promise you. So I was a bit concerned by a study that came out this week that offered a relatively simple solution to what is a really complex problem. Can you actually cut burnout in half by giving physicians a smartwatch? Before we dig into the study, let's talk about burnout a little bit. I think there's sort of a Potter Stewart definition of burnout: 'I know it when I see it.' But the real description comes from Christina Maslach, who characterized it as a psychological syndrome brought about by chronic occupational stress characterized by emotional exhaustion, depersonalization or cynicism, and a reduced sense of personal accomplishment. Sound familiar? I know. It's not uncommon. And it goes without saying that depersonalization and cynicism are just terrible traits to have in a doctor. It's not just workload that leads to burnout, according to most psychologists; it's this combination of workload and a feeling that you don't have autonomy. That you are not the master of your fate or the captain of your soul. Big issues. So how is a smartwatch supposed to help? Well, the idea isn't crazy. Smartwatches are miniature biofeedback devices. They tell you about your heart rate, your step count, how much you slept. Those little data points can lead to some real behavior change. This is anecdotal, but multiple people have told me they've cut back on drinking alcohol because they noticed that their smartwatch-reported sleep quality is worse on nights that they drink. Researchers at the Mayo Clinic and University of Colorado thought that maybe giving smartwatches to physicians would lead them to make small lifestyle changes, like getting more sleep, that would reduce this problem of burnout. Here's how the trial worked, as reported in JAMA Network Open . One hundred and eighty-four physicians — about half attendings, half residents and fellows, and about 60% female — were randomized to two groups. One group got a smartwatch, specifically the Venu 2 Plus from Garmin, to wear for 6 months. The other group got nothing. Well, to be fair, they got a smartwatch as well — just after a 6-month wait so the team would have 6 months of high-quality comparison data. At the beginning of the study and several times over those 6 months, the participants took surveys about their mental health: a resilience survey, a quality-of-life survey, a depression survey, a stress survey, a sleep survey and, importantly, a burnout survey. At baseline, 50% of people in the intervention arm were burned out and 43% were burned out in the control arm. After 6 months, burnout dropped to 41% in the intervention arm and rose to 51% in the control arm. The difference here was not technically statistically significant, but after accounting for the fact that burnout was higher at baseline in the intervention group, the team concluded that the odds of burnout were about 50% lower after 6 months of the smartwatch intervention. I know statistics can get confusing in situations like this. I think sometimes it helps just to look at the graph and make your own judgment: Burnout down a bit with a smartwatch, up a bit without a smartwatch. Fine. There was also about a 20% improvement in resilience scores, while there were no differences in quality of life, depression, or stress scores. So… is that it? Have we solved this problem plaguing all of healthcare and multiple other industries across the United States? Smartwatches? My fear is that some C-suite execs will look at this study and think they can cut burnout rates in half by sending a bunch of smartwatches around. Maybe it seems obvious to you that it wouldn't actually work, but let's break down a bit how the results of this study may be somewhat skewed. The most important thing to note is that this study was not blinded. The people in the smartwatch group knew they were in the smartwatch group because… they were wearing the smartwatch. It's hard to imagine a way to blind this study, to be fair, although I suppose you could give everyone a smartwatch but half the people get fake data or something. But once you know that you are in the intervention group, biases in your answers creep in. Just imagine you're in the study. At baseline, you take these surveys, then they give you a smartwatch, and 6 months later you take a bunch of surveys again. Maybe you skew your answers a bit, even unconsciously, because you like the people running the study or science in general, or maybe even smartwatches. The authors acknowledge this but minimize it, suggesting that if this 'social desirability bias' was present, it should improve scores across all the surveys. I mean, okay, but to be honest, the score differences are pretty marginal across the board, so I don't find that argument very compelling. The real issue here is that this study puts the locus of control in the wrong place, as many burnout interventions do. It puts the responsibility for burnout on the shoulders of the burned-out physicians. It suggests we can tolerate our jobs better if we just change our outlook: Sleep more, meditate more, live in the moment, do tai chi, etc. But I would argue that the problem with burnout is not in the mind of the physician; the problem is the system in which we work. More than 75% of physicians in the United States today are employed by hospitals, health systems, or other corporate entities. The private-practice model is rapidly dying and the physician workforce is learning what it means to be labor instead of management. They are feeling what it is like to be exploited, for lack of a better word — pushed to see more patients in less time, pushed to generate more RVUs, pushed to work weekends and nights to increase margins. It's not what they signed up for. The problem of burnout is from the system. If you want to cut rates in half, you don't send docs a smartwatch. You give them more time to see fewer patients. You change the insurance system that leaves us on the phone arguing for prior authorization for hours at a time. And if that affects the bottom line of the health system, you look for cuts in the — and this is true — 10 administrators for each physician in the US. Look, I love my smartwatch. It helps me delete emails while I'm waiting for the elevator. But the solution to physician burnout is not here. It's out there.
Yahoo
an hour ago
- Yahoo
TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation
Transforms present balance sheet with significant reduction in liabilities Largest shareholder is long-term strategic investor NEW YORK, August 19, 2025--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that is has significantly improved its financial position over the past 5 months through a material reduction in liabilities, while maintaining total assets of over $17 million as of June 30, 2025. "The recent significant improvement in our financial position gives TNF a stronger platform for growth opportunities and taking advantage of shareholder value creation opportunities," said TNF President and Chief Medical Officer, Mitchell Glass, M.D. "We are pleased to have the continued support of our largest investors, and look forward to updating investors on TNF's business developments in the near future, including our ongoing collaboration with Renova on GLP-induced inflammation and muscle damage." The improvements in the Company's financial position will be reflected in future financial statements of the Company. About TNF Pharmaceuticals, Inc. TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. Isomyosamine is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-α, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. Isomyosamine is being developed to treat diseases and disorders marked by acute or chronic inflammation. The Company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the rapidly growing CBD market, which includes both FDA approved drugs and CBD products not currently regulated as drugs. For more information, visit Cautionary Statement Regarding Forward-Looking Statements This press release may contain forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any expected future results, performance, or achievements. Forward-looking statements speak only as of the date they are made and neither the Company nor its affiliates assume any duty to update forward-looking statements. Words such as "anticipate," "believe," "could," "estimate," "expect," "may," "plan," "will," "would'' and other similar expressions are intended to identify these forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: unanticipated financial setbacks, the Company needing to pursue financing options that could adversely impact our liabilities due to adverse market conditions, the Company's ability to maintain compliance with the Nasdaq Stock Market's listing standards; the timing of, and the Company's ability to, obtain and maintain regulatory approvals for clinical trials of the Company's pharmaceutical candidates; the timing and results of the Company's planned clinical trials for its pharmaceutical candidates; the amount of funds the Company requires for its pharmaceutical candidates; increased levels of competition; changes in political, economic or regulatory conditions generally and in the markets in which the Company operates; the Company's ability to retain and attract senior management and other key employees; the Company's ability to quickly and effectively respond to new technological developments; and the Company's ability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others and prevent others from infringing on the Company's proprietary rights. A discussion of these and other factors with respect to the Company is set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed by the Company on April 11, 2025, and subsequent reports that the Company files with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and the Company disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise. View source version on Contacts Investor Contact: Sign in to access your portfolio
